887.8000 17.55 (2.02%)
NSE Jul 11, 2025 15:31 PM
Volume: 428.1K
 

887.80
2.02%
Geojit BNP Paribas
Strides reported its Q2FY22 revenue at Rs. 721cr, (4.8% QoQ, -9% YoY), enabled by a bounce back in the other regulated markets which was partially offset by an underperformance in the US markets. US markets (34% of total revenues) witnessed a 17% QoQ/-38% YoY...
Strides Pharma Science Ltd. is trading above its 150 day SMA of 704.8
More from Strides Pharma Science Ltd.
Recommended